Filter
274
Filtered Results: 274
Text search:
biotechnology
Featured
Recommendations
24
New Publications
57
Language
Document type
No document type
128
Studies & Reports
63
Guidelines
34
Manuals
22
Fact sheets
14
Strategic & Response Plan
8
Situation Updates
3
Training Material
2
Countries / Regions
India
39
Global
15
Bangladesh
6
Nepal
5
Rwanda
5
Western and Central Europe
4
South Africa
4
Nigeria
3
Africa
3
Uganda
3
Ethiopia
3
Myanmar / Burma
3
Colombia
2
Kenya
2
Cameroon
2
Syria
2
Zimbabwe
2
Mozambique
2
USA
2
Haiti
2
Asia
2
Tanzania
2
Germany
2
West and Central Africa
2
South–East Asia Region
2
Russia
2
Botswana
2
Thailand
1
Ukraine
1
Ghana
1
Benin
1
Sierra Leone
1
Iran
1
Senegal
1
Afghanistan
1
Peru
1
Malawi
1
Philippines
1
Guinea
1
Cambodia
1
Eastern Europe and Central Asia
1
Paraguay
1
East and Southern Africa
1
Southern Africa
1
Argentina
1
Vietnam
1
Brazil
1
Namibia
1
Sudan
1
Angola
1
Libya
1
Zambia
1
Iraq
1
Liberia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Guidelines
36
Drugs & Medical Equipment
21
Studies & Reports
21
Policies
15
COVID-19
13
Policies & Guidelines HIV & TB
6
Parasitology
5
Disaster Preparedness
4
Community Health
4
Capacity Building
4
Waste Management
4
Malaria
4
Food Security & Nutrition
4
General Guidelines
3
MPOX - Monkeypox
3
Infection Control & Prevention (IPC)
3
HIV & STI
3
TB
3
Paediatrics
2
Diabetes
2
Schistosomiasis
2
x MEDBOX Issue Brief & Annual Reports x
2
Virology
2
Pediatrics
2
Vaccine-preventable Diseases
2
Statistics
2
General Guidelines
2
Dengue
2
Disease Prevention & Control
2
Digital Health
1
Hepatitis
1
Family Planning
1
Pharmacy & Technology
1
Under-5 nutrition
1
Bacteriology
1
Laboratory Waste
1
Community Health
1
Health System Strengthening
1
Medical Devices & Equipment
1
Yellow Fever
1
Demograhic Health Surveys DHS
1
Women & Child Health
1
Disabilities
1
WASH
1
Non-communicable Diseases
1
Laboratory Quality Assurance
1
Age & Elderly
1
Radiology and Diagnostic
1
Toolboxes
Country specific
10
Country specific documents
9
Encyclical Letters
7
Waste Managment
7
Laboratory Guidance
6
Diagnostics & Laboratory Guidance
5
Influenza Prevention & Control
4
Public Health
4
Studies
4
Social Ethics
4
Fair Allocation & Ethical Aspects
4
General documents One Health
4
Preparedness, Response & Risk Communication
3
Clinical Guidelines
3
Global Impact: Socio-economic, health services, TB & HIV
3
Essential Medicines & Medical Devices
3
Communication Material
3
Waste Management
3
Biodiversity shift
3
MPOX - Monkeypox
3
Research & Access
3
Assessment & Studies
2
Biosafety
2
Preparedness, Response & Risk Communication
2
Research
2
International
2
Laboratory
2
Prevention & Preparedness
2
Context & Facts, Travel Advice
2
Country Specific
2
Catholic Social Teaching (CST)
2
Oxygen Therapy
2
Access & Strategy
2
Vaccine Hesitancy & Myths
2
Ethics
2
Climate Change General
2
Agriculture
2
Zoonoses
2
Others
2
MPOX - Monkeypox
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Detection & Diagnosis
2
General
2
Nutrition
2
Germany
2
Vision Loss & Blindness
2
Testing Guidelines
2
TB
2
Outbreak Prevention & Control
1
ART Drug Resistance
1
Local Action
1
General Reports
1
Surveillance
1
TB & Drug Abuse
1
HIV testing & services
1
IPC
1
Training
1
Surveillance
1
Background PTSD in children
1
Chemical Attacks
1
Treatment & Prevention
1
Vaccines & Immunization
1
Yellow Fever
1
Yellow Fever Prevention & Control
1
Prevention & Control
1
Key Resources
1
Adults
1
Introduction to Global Health
1
WASH
1
Influenza
1
Public Health
1
Treatment Guidelines HIV
1
Laboratory
1
Rwanda
1
Health Equity & Equality
1
Clinical aspects
1
Women's Mental Health
1
General
1
Treatment Guidelines
1
Supporting tools
1
Research & Development
1
Infection Control General
1
Surveillance & Contact tracing
1
Human Rights
1
Health Care Professionals & Spirituality
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
Immunization Guidelines
1
TB/HIV
1
Preparedness, Response & Risk Communication
1
Genomic sequencing
1
COVAX Initiative
1
Long COVID/ Post-COVID Syndrome
1
Sputnik V
1
Research & Pipeline
1
Standard Operating Procedure (SOP)
1
Planetary Health
1
Food environments
1
Overview & reports
1
Falsified & Substandard
1
Model Formulary
1
Pharmacy Management
1
Quality Assurance
1
Rational use of Medicine
1
Standard Operating Procedures (SOPs)
1
Traditional & Herbal Medicines
1
Strategies
1
Guiding documents and principles
1
Land-system change
1
Reports & Studies
1
Guidelines & Manuals
1
General
1
Infectious Diseases
1
Water Pollution
1
Health Impact & Climate Change
1
General
1
Nuclear & Chemical Hazards
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Overview, Studies & Reports
1
General Information
1
General Information & Methodology
1
Health Financing Toolbox
1
Prevention & Strategies
1
Studies & Reports
1
Clinical Aspects & Diagnosis
1
Capacity Building & Resources
1
Risk Factors
1
Women
1
General
1
Drug resistant TB
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
Bipolar Affective Disorders
1
Protection
1
TB & Prisoners
1
Training
1
Dengue Prevention & Control
1
HIV and coinfection
1
Others
1
Global Health Institutions and Stakeholders
1
WASH
1
Infection Control
1
Laboratory & Diagnostics
1
Global Health Action
1
AMR
1
Capacity Building
1
Neurological disorders, Others
1
Global Health Ethics
1
SEAR (South-east Asia Region)
1
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical ...
Antibiotics use with care
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan...
The Lancet. 13 March 2022. doi: 10.1016/S0140-6736(21)02868-3. Previous Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) studies have reported
national health estimates for Ethiopia. Substantial regional variations in socioeconomic status, population, demography, and access to hea...
PNAS 2022 Vol. 119 No. 7 e2109217118
The Faster We Go, the Health We'll Be.
The report outlines five climate solutions that research shows will deliver immediate, often localized, health and equity benefits. Our focus is on the solutions that proactively advance both health and health equity, recognizing that some of us face greater h...
A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Vol.399 Issue 10341 p.2129-2154
Human resources for health (HRH) include a range of occupations that aim to promote or improve human health. The UN Sustainable Development Goals (SDGs) and the WHO Health Workforce 2030 s...
Laboratory testing for the monkeypox virus
recommended
Any individual that meets the suspected case definition of monkeypox should be offered testing in appropriately equipped laboratories by staff trained in the relevant technical and safety procedures. Confirmation of monkeypox virus infection is based on nucleic acid amplification testing (NAAT), usi...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable development, human rights, and peace that governments are...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
